Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
Yuko MinouraMasato TakahashiHideki MaedaSayuri KuwaharaHanae TachikawaMitsugu YamamotoNobumoto TomiokaKenichi WatanabeAkihiro SakuraiPublished in: Breast cancer (Tokyo, Japan) (2022)
When considering BRCA1/2 genetic testing, FH of prostate, pancreatic, and skin cancers may also be examined as HBOC-related cancers to provide testing for patients who would benefit from it. However, further studies for the association between skin cancer and HBOC will be required because it has not been reported in Japan.